New Guidelines Broaden Statin Eligibility for Cardiovascular Disease Prevention

Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guidelines significantly expand statin therapy eligibility, potentially including 25 million more U.S. adults. This change emphasizes long-term atherosclerotic cardiovascular disease risk, aiming to enhance preventative treatment for a broader population.